Status:
UNKNOWN
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
DSM-5 Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse. Recent work shows th...
Detailed Description
Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.
Eligibility Criteria
Inclusion
- Patient over 18 years old
- With a diagnosis of schizophrenia according to DSM-5 criteria
- Accompanied by his main caregiver, who will be able to complete the questionnaires after having signed the information form.
- Treated with one or more antipsychotics.
- Able to complete the questionnaires related to the protocol
- Having agreed to sign the information form.
Exclusion
- Not understanding French, unable to answer questions linguistically
- Presenting an organic pathology and / or cognitive deterioration likely to hinder a good understanding of the interview
- Having already participated in the study
- presenting disorders related to the use of substances of severe intensity (such as acute intoxication, withdrawal syndrome or any state of delirium)
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03471013
Start Date
March 20 2018
End Date
March 30 2019
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Clermont-Ferrand
Clermont-Ferrand, France, 63003